https://doi.org/10.1186/s13054-020-03340-4
D
Dongni Hou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
732
Citations
13
h-index
18
i10-index
Dongni Hou is an academic researcher from Shanghai University. The author has contributed to research in topics: Chronic Obstructive Pulmonary Disease (COPD) Research & COVID-19 Clinical Research Studies & Respiratory Support and Mechanisms. The author has an h-index of 13, co-authored 52 publications.
ORCID: 0000-0001-8332-7321Papers by this author
worksCorticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis
2020 · Critical Care · 77 citations
Developing and validating a chronic obstructive pulmonary disease quick screening questionnaire using statistical learning models
2022 · Chronic Respiratory Disease · 4 citations
https://doi.org/10.1177/14799731221116585
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
2023 · Thrombosis Journal · 3 citations
https://doi.org/10.1186/s12959-023-00453-y
Impacts of COPD exacerbation history on mortality and severe cardiovascular events among patients with COPD in China: a retrospective cohort study
2025 · Respiratory Research · 2 citations
https://doi.org/10.1186/s12931-025-03316-4
Clinical prognosis and risk factors of death for COVID-19 patients complicated with coronary heart disease/diabetes/hypertension-a retrospective, real-world study
2024 · Clinical eHealth · 0 citations
https://doi.org/10.1016/j.ceh.2024.12.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat